RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced.
Eli Lilly And Company Type 2 Diabetes Drug Safe
Related posts:
- Boehringer Ingelheim And Lilly To Feature Type 2 Diabetes RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 7, 2011 /PRNewswire via COMTEX/...
- Boehringer Ingelheim Lilly Launch Diabetes Drug Tradjenta In US Earlier this year, Boehringer Ingelheim and Lilly collaborated in the...
- Boehringer Ingelheim Lilly Receive EU Approval For Linagliptin To Treat Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company today received Marketing...
- Boehringer Ingelheim And Lilly To Feature Type 2 Diabetes Research In More the companies' strengths as two of the world's leading pharmaceutical...
- Boehringer Ingelheim Eli Lilly Get EU Approval For Diabetes Drug Trajenta Boehringer Ingelheim and Eli Lilly and Company received Marketing Authorisation...